RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services, and Biogen Idec (NASDAQ: BIIB) have entered into a five-year strategic clinical development agreement. The multi-year collaboration is designed to leverage the expertise and experience from both organizations to optimize Biogen Idec’s clinical development processes.
Help employers find you! Check out all the jobs and post your resume.
